


Healthcare Industry News: HIV/AIDS
News Release - May 21, 2020
Cipla Receives Final Approval for Generic Version of Migranal(R) (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
Source: Cipla
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
